Latest News
Shuttle Pharmaceuticals Holdings, Inc.
- Shuttle Pharmaceuticals Dismisses Auditor Forvis Mazars, No Successor Engaged
- An auditor exit awaits Q3 reporting at Shuttle Pharma (SHPH), with no successor engaged as of Oct. 16.
- Which of Senti Biosciences (NASDAQ:SNTI), Autolus Therapeutics (NASDAQ:AUTL), Scinai Immunotherapeutics (NASDAQ:SCNI), Estrella Immunopharma (NASDAQ:ESLA) or Shuttle Pharmaceuticals (NASDAQ:SHPH) Is the Weakest Biotech or Pharma Decl
- Shuttle Pharmaceuticals (SHPH) Slips 1.83% to $5.35, Nearing Key Support - Sentiment Extreme
Headlines from the last 30 days, linking to the original publishers. See all market news →